908 Devices Inc. (MASS)
NASDAQ: MASS · Real-Time Price · USD
6.74
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Company Description

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications.

The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample.

It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas.

The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.

908 Devices Inc.
908 Devices logo
Country United States
Founded 2012
IPO Date Dec 18, 2020
Industry Medical Devices
Sector Healthcare
Employees 172
CEO Kevin Knopp

Contact Details

Address:
44 3rd Avenue
Burlington, Massachusetts 01803
United States
Phone 857-254-1500
Website 908devices.com

Stock Details

Ticker Symbol MASS
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $20.00
CIK Code 0001555279
CUSIP Number 65443P102
ISIN Number US65443P1021
Employer ID 45-4524096
SIC Code 3829

Key Executives

Name Position
Dr. Kevin J. Knopp Ph.D. Co-Founder, Chief Executive Officer, President and Director
Dr. Christopher David Brown Ph.D. Co-Founder, Board Advisor and Director
Joseph H. Griffith IV Chief Financial Officer and Treasurer
Mark S. Levine J.D. Chief Legal and Administrative Officer
Barbara Russo Vice President of Corporate Marketing and Communications
John Kenneweg Senior Vice President of Sales and Product Marketing
Don Osmer Vice President of Human Resources
Kevin McCallion Ph.D. Senior Vice President of Products and Production

Latest SEC Filings

Date Type Title
Apr 8, 2026 144 Filing
Apr 8, 2026 144 Filing
Mar 13, 2026 EFFECT Notice of Effectiveness
Mar 9, 2026 S-3 Registration statement under Securities Act of 1933
Mar 9, 2026 S-8 Securities to be offered to employees in employee benefit plans
Mar 9, 2026 10-K Annual Report
Mar 3, 2026 8-K Current Report
Feb 17, 2026 SCHEDULE 13G/A Filing
Feb 9, 2026 SCHEDULE 13G Filing
Jan 20, 2026 8-K Current Report